ASSET PURCHASE AGREEMENTAsset Purchase Agreement • April 1st, 2013 • Apricus Biosciences, Inc. • Pharmaceutical preparations • California
This Asset Purchase Agreement (this “Agreement”) is made and entered into as of the 26 day of March, 2013 (the “Effective Date”), by and between Apricus Pharmaceuticals USA, Inc., a Delaware corporation with its principal address at 11975 El Camino Real, Suite 300, San Diego, CA 92130 (“Seller”) and Biocodex, Inc., a Washington corporation with its principal address at 1250 Bayhill Drive, San Bruno, CA 94066, and its Affiliates (collectively, “Buyer”).
